Updated overview of the SEER-Medicare data: enhanced content and applications

L Enewold, H Parsons, L Zhao, D Bott… - JNCI …, 2020 - academic.oup.com
Abstract Background The National Cancer Institute's Surveillance, Epidemiology, and End
Results (SEER)-Medicare–linked database was first created almost 30 years ago. Over time …

Medical care costs associated with cancer survivorship in the United States

AB Mariotto, L Enewold, J Zhao, CA Zeruto… - … , biomarkers & prevention, 2020 - AACR
Background: The prevalence of cancer survivorship is increasing. In this study, we provide
contemporary population–based estimates and projections of the overall and site-specific …

Annual report to the nation on the status of cancer, part 2: patient economic burden associated with cancer care

KR Yabroff, A Mariotto, F Tangka, J Zhao… - JNCI: Journal of The …, 2021 - academic.oup.com
Abstract Background The American Cancer Society, National Cancer Institute, Centers for
Disease Control and Prevention, and North American Association of Central Cancer …

From APC to the genetics of hereditary and familial colon cancer syndromes

AP Olkinuora, PT Peltomäki, LA Aaltonen… - Human Molecular …, 2021 - academic.oup.com
Hereditary colorectal cancer (CRC) syndromes attributable to high penetrance mutations
represent 9–26% of young-onset CRC cases. The clinical significance of many of these …

Clinical benefits, harms, and cost-effectiveness of breast cancer screening for survivors of childhood cancer treated with chest radiation: a comparative modeling study

JM Yeh, KP Lowry, CB Schechter, LR Diller… - Annals of internal …, 2020 - acpjournals.org
Background: Surveillance with annual mammography and breast magnetic resonance
imaging (MRI) is recommended for female survivors of childhood cancer treated with chest …

Comparative effectiveness and cost-effectiveness of colorectal cancer screening with blood-based biomarkers (liquid biopsy) vs fecal tests or colonoscopy

U Ladabaum, A Mannalithara, Y Weng, RE Schoen… - Gastroenterology, 2024 - Elsevier
Background & Aims Colorectal cancer (CRC) screening is highly effective but underused.
Blood-based biomarkers (liquid biopsy) could improve screening participation. Methods …

Treatment costs of colorectal cancer by sex and age: population-based study on health insurance data from Germany

T Heisser, A Simon, J Hapfelmeier, M Hoffmeister… - Cancers, 2022 - mdpi.com
Simple Summary Screening for colorectal cancer (CRC) has considerably contributed to
declining CRC incidence and mortality rates in Germany over the last two decades …

Healthcare costs for medicare patients with hepatocellular carcinoma in the United States

MA Karim, M Ramezani, T Leroux, HC Kum… - Clinical …, 2023 - Elsevier
Background & Aims Hepatocellular carcinoma (HCC) has an increasing mortality in the
United States and is a leading cause of morbidity and mortality in patients with cirrhosis. We …

Direct Medical Spending on Young and Average-Age Onset Colorectal Cancer before and after Diagnosis: a Population-Based Costing Study

R Garg, EC Sayre, R Pataky, H McTaggart-Cowan… - … Biomarkers & Prevention, 2024 - AACR
Background: Despite a better understanding of the increasing incidence of young-onset
colorectal cancer (yCRC; age at diagnosis< 50 years), little is known about its economic …

Risk of anxiety and depression after diagnosis of young-onset colorectal cancer: A population-based cohort study

A Howren, EC Sayre, V Cheng, N Oveisi… - Current …, 2022 - mdpi.com
Given the increasing incidence of young-onset colorectal cancer (yCRC;< 50 years), we
aimed to evaluate the risk of depression and anxiety in individuals with yCRC in comparison …